Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

102.11 +0.33 (+0.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
News headline image
A New Groundbreaking Tool to Detect Colon Cancer Earlier
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This... 
Via PressReach
News headline image
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript ↗
EXAS earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates ↗
EXAS stock posted Q1 results that include a loss per share of 42 cents and revenue that was much better than analysts expected. 
Via InvestorPlace
News headline image
Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer ↗
The company sells Cologuard, a test to screen for colon cancer. 
Via Investor's Business Daily
News headline image
Analyst Ratings for Exact Sciences ↗
 
Via Benzinga
News headline image
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Preview For Exact Sciences ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 ↗
 
Via Benzinga
News headline image
3 Stocks That AI Predicts Will Outperform the Market ↗
Here are three stocks that came up when I asked the generative AI chatbot that powers Bing chat to make some AI stock recommendations 
Via InvestorPlace
News headline image
New Artificial Intelligence Tool Can Diagnose Colon Cancer
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and... 
Via PressReach
Topics Artificial Intelligence Death
News headline image
The 7 Best Biotech Stocks for Personalized Medicine Investors ↗
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
News headline image
Cathie Wood’s Next Big Bet: 3 Disruptive Innovations to Watch ↗
These Cathie Wood stocks could deliver massive gains in the coming years as they disrupt traditional industries. 
Via InvestorPlace
News headline image
What Has Cathie Wood Been Trading? ↗
The story of Ark Invest, Wall Street veteran Cathie Wood’s lineup of actively managed, innovation-centric ETFs is well-known at this point. Ark has been defined by big bets, big wins, big losses, and... 
Via Benzinga
News headline image
2 Supercharged Growth Stocks That Could Rocket 116% to 899% Higher, According to Wall Street ↗
Find out why expectations are so high for these two innovative businesses. 
Via The Motley Fool
News headline image
The 3 Best Millionaire-Maker Stocks to Buy for April 2023 ↗
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 
Via InvestorPlace
News headline image
3 Cathie Wood Stocks for Your April Must-Buy List ↗
Cathie Wood stocks are doing much better in 2023 than last year. Here are three to put on your April must-buy list. 
Via InvestorPlace
News headline image
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle ↗
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell. 
Via Investor's Business Daily
News headline image
3 Stocks With Superior Potential for Super-Sized Gains in 2023 ↗
Investing in stocks with potential is a great way to make money as long as you do your research and understand the risks involved. 
Via InvestorPlace
News headline image
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have Today ↗
Has this been a market-beating investment? 
Via The Motley Fool
News headline image
EXAS Stock Is a Hidden Gem in the Healthcare Sector for Bold Investors ↗
Patient investors who have room for an intriguing medical-niche investment in their portfolio should take a closer look at EXAS stock. 
Via InvestorPlace
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market... 
Via Benzinga
News headline image
7 Growth Stocks Sitting in a Sweet Spot ↗
Offering ample growth potential, and each attractively-priced, now's the time to buy these seven growth stocks. 
Via InvestorPlace
News headline image
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold ↗
It pays to be an innovator. 
Via The Motley Fool
News headline image
What You Missed On Wall Street On Thursday ↗
SVB Financial is lower after the company announced it was undertaking a strategic repositioning of its balance sheet and also provided a negative update to both Q1 and full-year 2023 guidance. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 ↗
 
Via Benzinga
News headline image
Cathie Wood Is Betting Big on These 5 AI Stocks ↗
Investors are betting on Cathie Wood again thanks to growing AI stocks interest. Wood's Ark Invest holds several compelling AI picks. 
Via InvestorPlace
News headline image
Exact Sciences (EXAS) Q4 2022 Earnings Call Transcript ↗
EXAS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
After-Hours Action: What's Going On With Exact Sciences Stock? ↗
Exact Sciences Corp (NASDAQ: EXAS) shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results. 
Via Benzinga
News headline image
Exact Sciences, Which Outperforms 95% Of All Stocks, Just Beat Quarterly Estimates ↗
Exact Sciences is leaned on Cologuard for strong fourth-quarter sales growth. 
Via Investor's Business Daily
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.